Topics

Government reforms of Category M reimbursement risk 'exacerbating' drug shortages, says PSNC

13:04 EDT 13 Sep 2019 | The Pharmaceutical Journal

The government risks making drugs shortages worse with its generics reimbursement reforms, unless the proposals are rolled out gradually, the Pharmaceutical Services Negotiating Committee has said.

Original Article: Government reforms of Category M reimbursement risk 'exacerbating' drug shortages, says PSNC

NEXT ARTICLE

More From BioPortfolio on "Government reforms of Category M reimbursement risk 'exacerbating' drug shortages, says PSNC"

Quick Search